BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Percentile
P100
Near historical high
vs 2Y Ago
34.8x
Strong expansion
Streak
3 yr
Consecutive growthAccelerating
PeriodValue
2025393.02%
202463.56%
202311.28%
2022-29.13%
20215.50%
2020-15.96%
20194.08%
2018-25.64%
2017-4.00%
2016-27.12%